33% Growth, but the Margin Question Defines H2
Revenue growth crushed expectations at 33% YoY, backed by a ₹2,580 Cr order book and major new OEM wins. But Q2's 8.2% EBITDA margin missed the full-year double-digit target, signalling that cost pass-through is the real execution gate.
₹1,342 Cr
+33% YoY, +10% QoQ
₹52 Cr
+46% YoY, +2% QoQ
8.2%
vs 10.5–11% H2 target
The quarter in numbers
Lumax posted its strongest quarter in recent memory: ₹1,342 Cr revenue, up 33% YoY, driven by LED penetration (now 63% of sales), new OEM wins (Tata Aeris, Honda 2W, VW/Skoda, Toyota Kirloskar), and wallet-share expansion. PAT jumped 46% to ₹52 Cr. The headline is impressive. But the foundation cracks when you look at margins: Q2 delivered 8.2% EBITDA, well below the full-year double-digit target and management's own H2 guidance of 10.5–11%. That gap—230 to 290 basis points—is the story of the quarter.
Material cost escalations (West Asia conflict, electronics inflation) hit H1 to the tune of 100–120 bps. Management has passed some of this through to customers via price increases, but the lag is real. The confidence that H2 will recover rests entirely on that recovery completing on schedule.
Claims from the call vs. what holds up
What changed on this call
Revenue guidance was raised from prior 15–20% full-year to 25%+. Q2's 33% YoY delivery now validates that higher bar, and the order book (₹2,580 Cr, up from prior ₹2,500 Cr) de-risks 2+ years of revenue visibility. Major OEM wins are now named: Maruti Suzuki wallet expanding 25–30% to 35–40%, Honda 2-Wheeler 20% to 50%, VW/Skoda 30% to 70% over 2–3 years, and new business with Toyota Kirloskar (~15–20% share). Cost escalations were quantified at 100–120 bps for H1, pinpointing West Asia geopolitical risk and electronics supply inflation as the culprits. Capex guidance remains ₹200–250 Cr for FY27 (H1 spent ₹80 Cr; H2 remainder committed to SOP projects). No revision to full-year double-digit EBITDA target, but the path depends entirely on H2 margin recovery.
How the street is positioned
The stock trades at ₹5,259 (as of 2026-11-03), neutral in momentum (RSI 46.9) and holding above its 20-day average. But it sits 24.2% below its all-time high, a significant drawdown that reflects investor caution on the margin narrative. Year-to-date the stock is up 17.4% from its 52-week low, suggesting some recovery of confidence. Foreign institutional ownership has ticked down slightly (−0.27pp to 1.36% in Q1 FY27), while domestic institutional ownership ticked up (+0.63pp to 6.71%), indicating a shift toward domestic demand. Promoter holding remains rock-solid at 75%, signalling insider confidence. Volume is normal—no panic selling or euphoric buying.
Revenue guidance raised to 25%+; Q2 delivery of 33% validates it
₹2,580 Cr order book with named OEM wins (Maruti, Honda, VW, Toyota) de-risks 2+ years
LED 63% of revenue; advanced lighting roadmap (ADB, localization) supports long-term margin expansion
SOP pathway clear: ₹1,500 Cr next-year revenue from order book
Q2 EBITDA margin (8.2%) below full-year double-digit target; H2 recovery unproven
Material cost escalations 100–120 bps only partially price-recovered; lag-time risk on margin
Top 5 OEMs = 66% of sales; customer concentration limits pricing power
West Asia geopolitical and electronics supply inflation; supply-chain volatility persists
Stock down 24.2% from ATH; FII trimming slightly while DII accumulates
Management confidence high and grounded in order book; no evasion on cost pressure or ADB timeline
Material cost escalation not fully price-recoverable
MediumWest Asia geopolitical tensions and electronics inflation (100–120 bps H1) are only partially recovered via price increases. If cost pressure persists or customer resistance to further price hikes emerges, H2 margin target (10.5–11%) will miss, forcing full-year double-digit EBITDA guidance to be withdrawn.
EBITDA margin guidance miss risk (H2 10.5–11% not achieved)
MediumQ2 delivered 8.2%; H2 requires 230–290 bps lift. This is the critical execution gate for the quarter. Any further material cost spike or delay in customer price acceptance will derail recovery timing and undermine confidence in 2–3 year margin trajectory.
Customer concentration (66% from top 5 OEMs)
MediumMaruti, Hyundai/SMG, M&M, HMSI, Tata dominate revenue. While wallet-share expansion is evident, any single customer inventory correction, model de-selection, or shift to a competing lighting supplier poses immediate volume and pricing risk. No significant new-customer diversification is visible yet.
Supply chain volatility (electronics import disruption)
Low–MediumLED chips, connectors, and electronic controls are 25–30% of cost and largely imported. West Asia conflict and electronics supply tightness create near-term disruption risk. Localization roadmap (LED 30–35% → 50%, SMT 100%, connectors 30–35%) mitigates over 2–3 years but is not immediate.
ADB adoption timeline and incremental margin benefit (5–7 years to mass-market)
LowAdvanced driver assistance (ADB) is positioned as a long-term margin lever, but management acknowledged 5–7 years before mass adoption. Near-term margin expansion relies on LED penetration and content lift, not new tech. If ADB ramp is slower than expected, long-term margin ceiling (13%+) may not materialize on the ₹9,000 Cr target.
1 · H2 EBITDA margin delivery (10.5–11%)
This is the execution gate. If Q3 shows margin improvement tracking toward 10.5–11%, confidence in cost recovery narrative is restored. If Q3 margin slips further (below 8.2%), full-year double-digit guidance is at risk and conviction turns to caution.
2 · OEM wallet-share progress and new customer wins
Watch for: Maruti headlamp/tail lamp wallet 25–30% → 35–40% confirmed in H2 orders, Honda 2W tail lamp ramp from 20% baseline, and VW/Skoda LED tail lamp expansion to 70%+ over next 2–3 years. Any slowdown in these wallet wins signals either competitive pressure or customer caution.
3 · SOP pathway: ₹2,580 Cr order book → ₹1,500 Cr next-year revenue
The order book de-risks growth only if 60% ships to SOP (production start) by FY27 year-end. Watch for capex spend updates (H2 remaining ₹120–170 Cr) and customer SOP timelines disclosed in FY28 guidance. Any slippage pushes ₹1,500 Cr revenue realization into FY28-29 instead.
Lumax delivered a quarter that is strong on volume and guidance, but challenged on margin. The 33% revenue growth is real, the order book is credible, and the OEM wallet-share expansion is concrete. But a company cannot rest on raised guidance when its own margin targets are at risk of being missed. The H2 margin recovery (10.5–11%) is not a stretch target—it is a baseline expectation management set itself in prior calls. If that recovery materializes, the stock re-rates. If it slips, the narrative shifts from growth momentum to execution risk.
The number to track from here is H2 EBITDA margin. That single metric will tell you whether this company can pass material costs to customers on schedule, or whether pricing power has limits in a competitive OEM market. Revenue is the lagging indicator; margins are the leading one.
Informational and educational content only. Not investment advice.